Japan gov't panel approves 2 iPS-derived drugs

Japan gov't panel approves 2 iPS-derived drugs

File photo taken on Jan. 23, 2024, at the University of Osaka in Suita, Osaka Prefecture, shows iPS cell-derived cardiomyocyte sheet to treat severe heart failure.

  • Product Code
  • ILEA005070744
  • Registered date
  • 2026/2/19 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2026 Kyodo News
  • Media size
  • 3485 × 2791 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 1.75(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan gov't panel approves 2 iPS-derived drugs

    Japan gov't panel approves 2 iPS-derived drugs

    University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
      Japan gov't panel approves 2 iPS-derived drugs

      Japan gov't panel approves 2 iPS-derived drugs

      University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
        Japan gov't panel approves 2 iPS-derived drugs

        Japan gov't panel approves 2 iPS-derived drugs

        University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
          Nobel laureate Kitagawa

          Nobel laureate Kitagawa

          Professor Susumu Kitagawa of Kyoto University, a co-winner of the 2025 Nobel Prize in chemistry, delivers a lecture on Jan. 7, 2026, in Sendai in Miyagi Prefecture, northeastern Japan.
            Nobel laureate Kitagawa

            Nobel laureate Kitagawa

            Professor Susumu Kitagawa of Kyoto University, a co-winner of the 2025 Nobel Prize in chemistry, delivers a lecture on Jan. 7, 2026, in Sendai in Miyagi Prefecture, northeastern Japan.
              Nobel laureate Kitagawa

              Nobel laureate Kitagawa

              Professor Susumu Kitagawa of Kyoto University, a co-winner of the year's Nobel Prize in chemistry, delivers a lecture on Dec. 24, 2025, at a Kindai University campus in Higashiosaka in Osaka Prefecture, western Japan.
                Nobel laureate Kitagawa

                Nobel laureate Kitagawa

                Professor Susumu Kitagawa of Kyoto University, a co-winner of the year's Nobel Prize in chemistry, delivers a lecture on Dec. 24, 2025, at a Kindai University campus in Higashiosaka in Osaka Prefecture, western Japan.
                  Nobel Prize in medicine winner Sakaguchi

                  Nobel Prize in medicine winner Sakaguchi

                  Shimon Sakaguchi, a distinguished professor at Osaka University, alongside his wife, Noriko, attends a press conference in Suita, Osaka Prefecture, western Japan, on Oct. 7, 2025, a day after being named the winner of the Nobel Prize in Physiology or Medicine, along with two American scientists, for "groundbreaking" discoveries on how the immune system is kept in check.
                    Nobel Prize in medicine winner Sakaguchi

                    Nobel Prize in medicine winner Sakaguchi

                    Combined photo shows Shimon Sakaguchi (L), a distinguished professor at Osaka University, in Osaka in western Japan, and Yoshinori Ohsumi, who won the Nobel Prize in physiology or medicine in 2016, in Oiso, Kanagawa Prefecture, near Tokyo, speaking on the phone after Sakaguchi was named the winner of the Nobel Prize in Physiology or Medicine with two American scientists the previous night for their "groundbreaking" discoveries on how the immune system is kept in check, on Oct. 6, 2025.
                      2025 Nobel laureate in medicine Sakaguchi

                      2025 Nobel laureate in medicine Sakaguchi

                      Shimon Sakaguchi, a distinguished professor at Osaka University, receives a bouquet in Suita, Osaka Prefecture, on Oct. 7, 2025, after being named the winner of the Nobel Prize in Physiology or Medicine with two American scientists the previous night for their "groundbreaking" discoveries on how the immune system is kept in check.